- Home
- APGE vs WULF Comparison
APGE vs WULF Comparison
Compare APGE & WULF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APGE
- WULF
- Stock Information
- Founded
- APGE 2022
- WULF 1952
- Country
- APGE United States
- WULF United States
- Employees
- APGE N/A
- WULF N/A
- Industry
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- WULF EDP Services
- Sector
- APGE Health Care
- WULF Technology
- Exchange
- APGE Nasdaq
- WULF Nasdaq
- Market Cap
- APGE 3.0B
- WULF 2.6B
- IPO Year
- APGE 2023
- WULF 1995
- Fundamental
- Price
- APGE $37.06
- WULF $6.40
- Analyst Decision
- APGE Strong Buy
- WULF Strong Buy
- Analyst Count
- APGE 5
- WULF 9
- Target Price
- APGE $83.50
- WULF $7.97
- AVG Volume (30 Days)
- APGE 488.2K
- WULF 32.1M
- Earning Date
- APGE 03-04-2025
- WULF 11-12-2024
- Dividend Yield
- APGE N/A
- WULF N/A
- EPS Growth
- APGE N/A
- WULF N/A
- EPS
- APGE N/A
- WULF N/A
- Revenue
- APGE N/A
- WULF $128,351,000.00
- Revenue This Year
- APGE N/A
- WULF $110.37
- Revenue Next Year
- APGE N/A
- WULF $106.76
- P/E Ratio
- APGE N/A
- WULF N/A
- Revenue Growth
- APGE N/A
- WULF 131.22
- 52 Week Low
- APGE $31.75
- WULF $1.24
- 52 Week High
- APGE $72.29
- WULF $9.30
- Technical
- Relative Strength Index (RSI)
- APGE 32.29
- WULF 51.60
- Support Level
- APGE $36.48
- WULF $5.82
- Resistance Level
- APGE $42.98
- WULF $6.33
- Average True Range (ATR)
- APGE 2.92
- WULF 0.52
- MACD
- APGE -0.99
- WULF 0.07
- Stochastic Oscillator
- APGE 4.12
- WULF 84.62
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Its two programs are APG777 and APG808, which initially develop for treating AD and COPD, respectively.
About WULF TeraWulf Inc.
TeraWulf Inc is a digital asset technology company that is engaged in digital infrastructure and sustainable energy development. The company's primary focus is supporting environmentally conscious bitcoin mining operations by developing and operating facilities within the United States. The company's bitcoin mining facilities are powered by clean, affordable, and reliable energy sources. The company's primary source of revenue stems from the mining of bitcoin conducted at the company's mining facility sites. Additionally, the company occasionally generates revenue through the provision of miner hosting services to third-party entities.